Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at pembrolizumab for women with ovarian cancer (KEYNOTE-100)

Overview

Cancer types:

Ovarian cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is for women with ovarian cancer that has come back (recurrent cancer) after having surgery and platinum chemotherapy. Platinum chemotherapy includes the drugs cisplatin, carboplatin and oxaliplatin.

It is for women who have:

  • epithelial ovarian cancer

  • fallopian tube cancer

  • primary peritoneal cancer

These cancers are treated in the same way, so when we use the term ovarian cancer in this summary, we are referring to all three.

Recruitment start: 27 May 2016

Recruitment end: 8 September 2016

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Jonathan Ledermann

Supported by

Merck Sharp & Dohme Ltd

Last reviewed: 25 Jan 2017

CRUK internal database number: 14100

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.